Page 164 - Iontech News Today

WASHINGTON (AP) — The Food and Drug Administration on Friday paved the way for children...

(The Center Square) – The U.S. Food and Drug Administration on Friday granted approval for the Pfizer-BioNTechs COVID-19 vaccine to be administered to children ages 5 to 11.

There are many social media posts claiming that the coronavirus vaccines are causing adverse effects to recipients.The claims come as the U.S. FDA is expected to support its panel's recommendations of authorizing the use of Pfizer's coronavirus vaccine on children aged five to 11 years.

Doses expected to be delivered by April 2022 Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. government has purchased 50 million more doses of the companies' COVID-19

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and BioNTech SE (BNTX) said that they will provide the U.S. Government an additional 50 million pediatric doses of their COVID-19 vaccine.The U.S. will

Pfizer and BioNTech said on Thursday they expect to deliver 50 million more doses of their COVID-19 vaccine to the US government by April-end, as the country prepares to vaccinate children.

A Food and Drug Administration advisory panel voted unanimously, with one abstention, that the vaccine's benefits in preventing COVID-19 in that age group outweigh any potential risks including a heart-related side effect that's been very rare in teens and young adults despite their use of a much higher shot dose.

San Antonio-area government and public health officials were encouraged Tuesday by a U.S....

OLYMPIA, Wash. (AP) — Health officials in Washington said Wednesday they are expecting...

OLYMPIA, Wash. (AP) — Health officials in Washington said Wednesday they are expecting...